Jelena Zurovac , Eunhae Shin , Joel Earlywine , Arkadipta Ghosh , Jonathan Brown
{"title":"在医疗保险受益人中,综合初级保健加和阿片类药物处方和处方填充之间的关系。","authors":"Jelena Zurovac , Eunhae Shin , Joel Earlywine , Arkadipta Ghosh , Jonathan Brown","doi":"10.1016/j.josat.2024.209621","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><div>To examine if Medicare beneficiaries attributed to Comprehensive Primary Care Plus (CPC+) practices had a greater decrease in the potential overuse of prescription opioids relative to beneficiaries attributed to other primary care practices. Primary care practices that participated in CPC+ received enhanced Medicare payment to support five functions: access and continuity of care, care management, comprehensiveness and coordination, patient and caregiver engagement, and planned care and population health. CPC+ practices participated within two tracks starting in 2017; Track 2 practices received larger payments to support more enhanced care delivery than Track 1 practices.</div></div><div><h3>Methods</h3><div>Employing difference-in-differences, we used Medicare claims and Part D data to examine changes in potential opioid overuse between 2016 (baseline) and 2021 (the fifth program year). Our measure of potential opioid overuse measure relies on specifications for an existing quality measure of the same name that is defined as filling opioid prescriptions at a daily dosage of 90 morphine milligram equivalents or more among beneficiaries who use opioids for at least 90 days of supply per year. A total of 40,219 Medicare fee-for-service beneficiaries used opioids long term and were attributed to 2888 CPC+ practices; 129,178 beneficiaries used opioids long term and were attributed to 6921 comparison practices.</div></div><div><h3>Results</h3><div>Across the combined treatment and comparison groups, potential opioid overuse decreased from 19 % in 2016 to 12 % in 2021. Relative to the comparison group, beneficiaries attributed to Track 1 CPC+ practices experienced an 0.8 percentage point greater decrease in potential opioid overuse (95 % CI = −1.4, −0.2) in the third program year compared to baseline. These findings persisted in the fourth and fifth years and were similar in magnitude to those in the third year. Track 2 results were similar to Track 1 results. The findings were likely driven by changes in CPC+ clinicians' prescribing behaviors: clinicians in CPC+ practices reduced the average dosage and the number of days' supply of prescription opioids more than clinicians in comparison practices.</div></div><div><h3>Conclusions</h3><div>A large-scale primary care delivery transformation initiative was associated with reduced potential opioid overuse among Medicare beneficiaries.</div></div>","PeriodicalId":73960,"journal":{"name":"Journal of substance use and addiction treatment","volume":"170 ","pages":"Article 209621"},"PeriodicalIF":0.0000,"publicationDate":"2024-12-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between Comprehensive Primary Care Plus and opioid prescribing and prescription fills among Medicare beneficiaries\",\"authors\":\"Jelena Zurovac , Eunhae Shin , Joel Earlywine , Arkadipta Ghosh , Jonathan Brown\",\"doi\":\"10.1016/j.josat.2024.209621\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><div>To examine if Medicare beneficiaries attributed to Comprehensive Primary Care Plus (CPC+) practices had a greater decrease in the potential overuse of prescription opioids relative to beneficiaries attributed to other primary care practices. Primary care practices that participated in CPC+ received enhanced Medicare payment to support five functions: access and continuity of care, care management, comprehensiveness and coordination, patient and caregiver engagement, and planned care and population health. CPC+ practices participated within two tracks starting in 2017; Track 2 practices received larger payments to support more enhanced care delivery than Track 1 practices.</div></div><div><h3>Methods</h3><div>Employing difference-in-differences, we used Medicare claims and Part D data to examine changes in potential opioid overuse between 2016 (baseline) and 2021 (the fifth program year). Our measure of potential opioid overuse measure relies on specifications for an existing quality measure of the same name that is defined as filling opioid prescriptions at a daily dosage of 90 morphine milligram equivalents or more among beneficiaries who use opioids for at least 90 days of supply per year. A total of 40,219 Medicare fee-for-service beneficiaries used opioids long term and were attributed to 2888 CPC+ practices; 129,178 beneficiaries used opioids long term and were attributed to 6921 comparison practices.</div></div><div><h3>Results</h3><div>Across the combined treatment and comparison groups, potential opioid overuse decreased from 19 % in 2016 to 12 % in 2021. Relative to the comparison group, beneficiaries attributed to Track 1 CPC+ practices experienced an 0.8 percentage point greater decrease in potential opioid overuse (95 % CI = −1.4, −0.2) in the third program year compared to baseline. These findings persisted in the fourth and fifth years and were similar in magnitude to those in the third year. Track 2 results were similar to Track 1 results. The findings were likely driven by changes in CPC+ clinicians' prescribing behaviors: clinicians in CPC+ practices reduced the average dosage and the number of days' supply of prescription opioids more than clinicians in comparison practices.</div></div><div><h3>Conclusions</h3><div>A large-scale primary care delivery transformation initiative was associated with reduced potential opioid overuse among Medicare beneficiaries.</div></div>\",\"PeriodicalId\":73960,\"journal\":{\"name\":\"Journal of substance use and addiction treatment\",\"volume\":\"170 \",\"pages\":\"Article 209621\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-12-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of substance use and addiction treatment\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2949875924003333\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"0\",\"JCRName\":\"PSYCHOLOGY, CLINICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of substance use and addiction treatment","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2949875924003333","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"0","JCRName":"PSYCHOLOGY, CLINICAL","Score":null,"Total":0}
引用次数: 0
摘要
前言:研究是否归因于综合初级保健加(CPC+)做法的医疗保险受益人相对于归因于其他初级保健做法的受益人有更大的减少处方阿片类药物的潜在过度使用。参与CPC+的初级保健实践获得了更多的医疗保险支付,以支持五项职能:护理的获取和连续性、护理管理、综合性和协调性、患者和护理人员的参与以及计划护理和人口健康。CPC+实践从2017年开始分两条轨道参与;轨道2的实践比轨道1的实践获得了更多的支付,以支持更多的增强护理服务。方法:使用差异中的差异,我们使用医疗保险索赔和D部分数据来检查2016年(基线)和2021年(第五个项目年)之间潜在阿片类药物过度使用的变化。我们对潜在阿片类药物过度使用措施的衡量标准依赖于现有的同名质量衡量标准,该标准被定义为在每年使用阿片类药物至少90 天供应的受益人中,以每日90吗啡毫克当量或更多的剂量填写阿片类药物处方。共有40,219名医疗保险按服务收费受益人长期使用阿片类药物,并归因于2888种CPC+做法;129,178名受益人长期使用阿片类药物,并归因于6921种比较做法。结果:在联合治疗组和对照组中,潜在的阿片类药物过度使用从2016年的19% %下降到2021年的12% %。与对照组相比,Track 1 CPC+实践的受益人在第三个项目年与基线相比,潜在的阿片类药物过度使用减少了0.8个百分点(95 % CI = -1.4,-0.2)。这些发现在第4年和第5年仍然存在,并且在规模上与第3年相似。第二阶段的结果与第一阶段的结果相似。这些发现可能是由CPC+临床医生处方行为的变化驱动的:CPC+实践的临床医生比比较实践的临床医生更多地减少了处方阿片类药物的平均剂量和供应天数。结论:大规模的初级保健服务转型倡议与减少医疗保险受益人中潜在的阿片类药物过度使用有关。
Association between Comprehensive Primary Care Plus and opioid prescribing and prescription fills among Medicare beneficiaries
Introduction
To examine if Medicare beneficiaries attributed to Comprehensive Primary Care Plus (CPC+) practices had a greater decrease in the potential overuse of prescription opioids relative to beneficiaries attributed to other primary care practices. Primary care practices that participated in CPC+ received enhanced Medicare payment to support five functions: access and continuity of care, care management, comprehensiveness and coordination, patient and caregiver engagement, and planned care and population health. CPC+ practices participated within two tracks starting in 2017; Track 2 practices received larger payments to support more enhanced care delivery than Track 1 practices.
Methods
Employing difference-in-differences, we used Medicare claims and Part D data to examine changes in potential opioid overuse between 2016 (baseline) and 2021 (the fifth program year). Our measure of potential opioid overuse measure relies on specifications for an existing quality measure of the same name that is defined as filling opioid prescriptions at a daily dosage of 90 morphine milligram equivalents or more among beneficiaries who use opioids for at least 90 days of supply per year. A total of 40,219 Medicare fee-for-service beneficiaries used opioids long term and were attributed to 2888 CPC+ practices; 129,178 beneficiaries used opioids long term and were attributed to 6921 comparison practices.
Results
Across the combined treatment and comparison groups, potential opioid overuse decreased from 19 % in 2016 to 12 % in 2021. Relative to the comparison group, beneficiaries attributed to Track 1 CPC+ practices experienced an 0.8 percentage point greater decrease in potential opioid overuse (95 % CI = −1.4, −0.2) in the third program year compared to baseline. These findings persisted in the fourth and fifth years and were similar in magnitude to those in the third year. Track 2 results were similar to Track 1 results. The findings were likely driven by changes in CPC+ clinicians' prescribing behaviors: clinicians in CPC+ practices reduced the average dosage and the number of days' supply of prescription opioids more than clinicians in comparison practices.
Conclusions
A large-scale primary care delivery transformation initiative was associated with reduced potential opioid overuse among Medicare beneficiaries.